A False Claims Act suit alleging
The two public sources on which the district court based its dismissal don’t trigger the FCA’s public disclosure bar because they don’t provide enough detail to support a claim that ESI—now known as Evernorth Health Inc.—engaged in a practice of fraudulently overfilling prescriptions, the US Court of Appeals for the Ninth Circuit said in a Tuesday opinion.
The relator, referred to as 3729 LLC, filed the suit ...
Learn more about Bloomberg Law or Log In to keep reading:
Learn About Bloomberg Law
AI-powered legal analytics, workflow tools and premium legal & business news.
Already a subscriber?
Log in to keep reading or access research tools.